Bortezomib - NDC Database (Page 2)

29 records found
Page:First Page2
70511-162 Aug 10, 2022
Bortezomib 2.5 mg Intravenous Injection by Maia Pharmaceuticals, Inc.
70710-1411 May 02, 2022
Bortezomib 1 mg/ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Zydus Pharmaceuticals USA Inc.
70771-1708 May 02, 2022
Bortezomib 1 mg/ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Zydus Lifesciences Limited
70860-225 May 06, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Athenex Pharmaceutical Division, LLC.
71288-118 Jul 26, 2022
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
72205-183 Jul 26, 2022
Bortezomib 3.5 mg/3.5ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Novadoz Pharmaceuticals LLC
72266-243 Aug 23, 2022
Bortezomib 1 mg Intravenous Injection by Fosun Pharma USA Inc
72266-244 Aug 23, 2022
Bortezomib 2.5 mg Intravenous Injection by Fosun Pharma USA Inc
83090-008 Jul 15, 2023
Bortezomib 3.5 mg/3.5ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Sintetica Us LLC
Page:First Page2
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.